| All hypertensive patients | Newly registered hypertensive patients | ||||
---|---|---|---|---|---|---|
Variable | Odds ratio | 95% CI‡ | P value | Odds ratio | 95% CI | P value |
NICE2 | 1.44 | 1.19–1.75 | <0.0001 | 1.62 | 1.10–2.36 | 0.013 |
References period between 2000–2005 |  |  |  |  |  |  |
Interaction term NICE* guidelines groups | Â | Â | Â | Â | Â | Â |
Younger non–black patients* NICE | 1.49 | 1.17–1.91 | 0.001 | 1.83 | 1.17–2.87 | 0,008 |
Older non black patients* NICE | 0.58 | 0.46–0.74 | <0.0001 | 0.56 | 0.39–0.77 | 0.001 |
Reference | Â | Â | Â | Â | Â | Â |
Black patients* period between 2000–2005 |  |  |  |  |  |  |
NICE patients groups | Â | Â | Â | Â | Â | Â |
Younger non–black patients | 0.16 | 0.12–0.21 | <0.0001 | 0.12 | 0.07–0.19 | <0.0001 |
Older non–black patients | 0.49 | 0.37–0.65 | <0.0001 | 0.55 | 0.39–0.77 | 0.001 |
Reference non–black patients |  |  |  |  |  |  |
Year | 1.02 | 0.98–1.05 | 0.247 | 1.10 | 1.01–1.20 | 0.037 |
Sex | 0.89 | 0.79–1.00 | 0.079 | 1.00 | 0.84–1.19 | 0.977 |
Reference female | Â | Â | Â | Â | Â | Â |
BHS3 | 1.06 | 0.98–1.15 | 0.119 | 0.85 | 0.65–1.08 | 0.190 |
Reference period between 2000 and 2003 | Â | Â | Â | Â | Â | Â |